Media News

Flexsys Narrows 6PPD Replacement to Two Final Molecules and Enters Cooperative Research and Development Agreement with U.S. Geological Survey for Independent Toxicity Testing

These two steps bring a 6PPD replacement closer to market, as federal scientists will conduct extensive aquatic toxicity testing - a critical step toward final molecule selection and commercialization. AKRON, Ohio, Aug. 27, 2026 /PRNewswire/ -- Flexsys, a global leader in material science and advanced tire additives solutions, today announces two milestones in the effort to develop...

CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

CS2009 Achieved Key Clinical Validations for Efficacy and Safety As of August 2026, updated data further confirmed the favorable safety profile of CS2009 and demonstrated strengthened efficacy across multiple key cohorts compared with the data presented at ASCO in May 2026. With expanded patient enrollment and longer follow-up, improvements were observed in both the objective response rate (ORR)...

Harbour BioMed Appoints Mr. Youchen Chen and Dr. Ian Y. Liu as Executive Directors

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 27, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Mr. Youchen Chen, Chief Financial Officer, and Dr. Ian...

Harbour BioMed Reports 2026 Interim Results: Three Integrated Growth Engines Accelerate Execution of Its Platform-Based Strategy

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 27, 2026 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced its interim results for the six months ended June 30,...

ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS

Now spanning ZEISS Retina and Cataract Workflows, the EVA NEXUS™ ophthalmic surgical system from ZEISS comes in a cataract-only configuration, bringing a tailored approach to different surgical needs. JENA, Germany, Aug. 27, 2026 /PRNewswire/ -- | Carl Zeiss Meditec AG The EVA NEXUS™ ophthalmic surgical system from ZEISS in a...

Neurophet Supplies ‘Neurophet AQUA’ and ‘Neurophet AQUA AD Plus’ to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market

Provides solutions for analyzing brain atrophy and white matter hyperintensities, as well as monitoring side effects associated with Alzheimer's disease treatments Secures a key reference site at a U.S. medical institution specializing in neurological disorders, accelerating product adoption across major healthcare institutions in North America SEOUL, South Korea, Aug....

Neopharma Technologies Achieves ISO/IEC 42001:2023 AI Management System Certification for NEOVAULT® Global Diagnostics Platform

Certification strengthens the governance framework behind NEOVAULT® as Neopharma expands from Fit-for-Duty into broader human health diagnostics NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Neopharma Technologies Ltd ("Neopharma") today announced that it has achieved ISO/IEC 42001:2023 certification for its Artificial Intelligence Management System (AIMS), marking an important milestone in the continued global development and deployment of its NEOVAULT®...

AsiaPay Partners with Generika Drugstore to Launch a Convenient and Secure Digital Payment Solution, Enhancing Customer Payment Experience in The Philippines

MANILA, Philippines, Aug. 27, 2026 /PRNewswire/ -- AsiaPay, a leading digital payment service provider and technology company in Asia, has partnered with Generika Drugstore, the country's premier generic pharma retail chain and part of AC Health, the healthcare arm of the Ayala Group, to significantly enhance the pharmacy's digital payment infrastructure....

Sunway Medical Centre Penang Receives Dual Honours at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition for Healthcare Excellence and Brand Leadership

SINGAPORE, Aug. 27, 2026 /PRNewswire/ -- Sunway Medical Centre Penang (SMCP) has been honoured with the Corporate Excellence and Inspirational Brand awards at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition by Enterprise Asia, recognising its strong growth trajectory as a leading tertiary healthcare provider and its commitment to delivering high-quality, patient-centred care across Malaysia. As the...

Bowtie Takes Lead in Responding to HKFI’s “Best Practice on Critical Illness Definitions Standardization”

Upholding the "Meet-or-Better-Off" Principle: Extending Upgrades to Not Only New Policies But Also Existing Customers HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Bowtie Life Insurance Company Limited ("Bowtie"), Hong Kong's first virtual insurer, today announced that it will fully adopt the "Best Practice on Critical Illness Definitions Standardization" launched by the Hong Kong Federation of Insurers ("HKFI"). Effective 1...